期刊文献+

硫酸异帕米星治疗泌尿系感染107例的临床观察 被引量:8

Clinical Effect of Isepamicin Sulfate on 107 cases of Urinary Tract Infections
下载PDF
导出
摘要 目的观察硫酸异帕米星治疗泌尿系感染的疗效和安全性。方法选择2008年05月至2008年12月期间我科在门诊或住院就诊、经尿培养证实的各种泌尿系感染患者107例,其中男67例,女40例,予硫酸异帕米星注射液(依克沙,日本旭化成制药株式会社出品)400 mg,1次/天静脉滴注。记录患者治疗前后的症状、体征变化及血、尿常规、肝肾功能情况,并行中段尿培养。同时记录药物不良反应。结果107例中治愈61例,显效23例,有效21例,无效2例。总有效率为98.1%。总体细菌清除率为96.7%。发生不良反应患者2例,6例次,分别为耳鸣1例次、听力障碍1例次、皮疹1例次、消化道反应1例次,实验室检查发现血清尿素氮一过性升高1例次、血肌酐一过性升高1例次。不良反应总体发生率为1.87%。结论硫酸异帕米星(依克沙)抗菌谱广,抗菌活性强,安全性好,非常适于治疗各类泌尿系感染。 Objective To investigate the clinical effect and safety of isepamicin sulfate in patients of urinary tract infections (UTIs). Methods 107 cases of urinary tract infection patients were enrolled from outpatient unit and inpatient unit of our departments during May. 2008 and December. 2008. All of the patients were diagnosed as UTIs according to uninne culture and bacterial identification. After enrollment, they were administered isepamicin sulfate injection 400 mg * qd intravenously guttae. The symptoms and sign were observed pre- and post-therapy, other laboratory index included blood routine, urine routine, blood urine nitrogen and serum creatinine, liver function, and medistream urine culture was performed before and post drug administration. All the side and toxic effects were recorded in detail. Results In 107 cases of UTIs, 61 were cured, 23 were excellently improved, 21 were partially improved and only 2 cases were inefficient. The total percentage of efficiency was 98.1%. The successful bacterial clearance ratio was 96.7%. Side effects happened in 2 patients including 6 episodes: 1 episode of tinnitus (0.93%), 1 episode of hearing disorder (0.93%), 1 episode of rash (0. 93% ), 1 episode of gastrointestinal disorder (0.93%), and 1 episode of temporary elevated blood urine nitrogen and serum ereatinine levels (0.93%). Total incidence of side effects was 1.87%. Conclusion Isepamicin sulfate has wide antimicrobial spectrum and powerful antimicrobial activity, the safeness is also reliable. It is recommended that isepamicin sulfate is quite suitable for therapy of kinds of urinary tract infections.
出处 《中国现代药物应用》 2009年第14期12-14,共3页 Chinese Journal of Modern Drug Application
关键词 硫酸异帕米星 感染 泌尿系 治疗 Isepamiein sulfate, infection, urinary tract, therapy
  • 相关文献

参考文献7

  • 1中华人民共和国卫生部药政局.新药(西药)临床指导原则汇编-抗菌药物指导原则,1993,7.
  • 2谢丹.异帕米星的临床药理与应用[J].重庆医学,2005,34(5):789-790. 被引量:2
  • 3Nishimura M, Kumamoto Y, Hirose T, et al. Significance of the combined treatment with isepamicin and piperacillin in an in vitro model for complicated cystitis operated by automatic simulator apparatus for urinary concentration. Kansenshogaku Zasshi. 1992; 66(1) : 6-13.
  • 4张敬德,汪复,周乐,吴培澄,刘裕昆,戴自英.Isepamicin与六种氨基糖苷类体外抗菌活性研究[J].中国抗生素杂志,1992,17(3):179-184. 被引量:7
  • 5Okubo T , Tyobe S. Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods . Jpn J Antibiot, 2006, 55(5) :514.
  • 6叶绪富,孔海深.2704例泌尿系感染者病原菌及耐药性分析[J].现代实用医学,2006,18(9):658-659. 被引量:10
  • 7Shigehara K, Miyagi T, Nakashima T, et al. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother,2008,14 ( 1 ) : 40-43.

二级参考文献26

  • 1TOd M, Minozzi C,Beaucaire D,et al. Isepmicin in intensiver care unit patients with nosocornial pneumonia: population pharmacokinetiecpharmacodynamic study [J].J Anti Chernother, 1999,44 .. 99.
  • 2腾正孝,齐腾焉.New antimicrobial agents[J].Jpn J Antibiot,1989,42:543.
  • 3Hatala R,Dinh TT,I。ook DJ.Single daily dosing of aminoglycosides in immunocompromissed adults:a systematic review[J].Clin Infect Dis,1997,24:810.
  • 4松本,一彦,博子,等.HAPA—Bの肾毒性试验[J].Chemotnerapy,1985,33(5):47.
  • 5Yazaki T, Yoshiyama Y, Wong P, et al. protective effect of flexoxacin against the nephrotoxicity of isepamicin in rats[J]. Biol Pharm Bull,2002,25(4) :516.
  • 6Liu M, Kato M, Hachimoto Y. Neuromuscular blocking effects of aminoglycoside antibiotics arbekacim, astromicin,isepamicin and netilmicin on the diaphragm and limb muscles in the rabbit[J]. Pharmacology,2001,63(3) :142.
  • 7Kafetzis DA,Maltezou HC, Marrikou M,et al. Iseparnicn versus arnikacirn for the treatment of acute pyelonephritis in children[J]. Int J Antirnierob Agents, 2002,14 : 51.
  • 8Colardy F. The efficacy and safety of isepamicin and ceftazidime compared with Amikacin and Cftazidime in acute lower respiratory tract infection[J]. Infect J Chemother, 1995,7(2) : 129.
  • 9Okubo T, Tyobe S. Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods [J]. Jpn J Antibiot, 2002,55(5)..514.
  • 10yamada H, Takahata M, Minami S,et al. In vitro interaction of tazobactam/piperacillin combined with aminoglycosiders against pseudomonas aeruginosa,klebsiella pneumonia,Escherichia coli and staphylococcus aureues[J].Jpn J Antibiot,2002,55(1):61.

共引文献16

同被引文献73

引证文献8

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部